Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Breast Cancer (Tokyo, Japan)|January 4, 2024
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapyNaruto Taira, Yuichiro Kikawa, Takayuki Iwamoto, et al.
Breast Cancer (Tokyo, Japan)|April 10, 2025
Validation of the Symptom Illustration Scale within an electronic Patient-Reported Outcomes Monitoring environment for metastatic breast cancer patients undergoing chemotherapyAzusa Jo, Takayuki Iwamoto, Youko Suzuki, et al.
Breast Cancer (Tokyo, Japan)|June 28, 2018
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancerDaisuke Takabatake, Yukiko Kajiwara, Shoichiro Ohtani, et al.
Breast Cancer Research and Treatment|September 9, 2023
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancerShinsuke Sasada, Naoto Kondo, Hiroya Hashimoto, et al.
International Journal of Molecular Sciences|December 10, 2021
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance DevelopmentMiwa Fujihara, Tadahiko Shien, Kazuhiko Shien, et al.
British Journal of Cancer|July 4, 2025
Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trialTadahiko Shien, Fumikata Hara, Kenjiro Aogi, et al.
Acta Medica Okayama|December 22, 2022
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer PatientsYuko Abe, Naruto Taira, Kosuke Kashiwabara, et al.
Annals of Surgical Oncology|November 13, 2022
Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local RecurrencesAyu Yamaguchi, Makoto Ishitobi, Naomi Nagura, et al.
Breast Cancer (Tokyo, Japan)|June 10, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancerTsuguo Iwatani, Norikazu Masuda, Shigehira Saji, et al.
Breast Cancer (Tokyo, Japan)|November 13, 2020
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese womenKengo Kawada, Naruto Taira, Taeko Mizoo, et al.
Pageof 16